However, in conditions such as sickle cell disease, glucose‐6‐phosphate dehydrogenase deficiency, hemodialysis, recent bleeding or transfusion, and erythropoietin therapy, the diagnosis of diabetes must be based on the measurement of venous plasma glucose levels, and HbA1c cannot be used.13 This evidence concerns the gene EPO and sickle cell disease.